Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-38,059
Closed -$1.4M 1410
2023
Q3
$1.4M Buy
+38,059
New +$1.52M 0.01% 829
2023
Q2
Sell
-54,683
Closed -$2.24M 1806
2023
Q1
$2.24M Buy
+54,683
New +$2.28M 0.02% 825
2021
Q1
Sell
-7,996
Closed -$278K 2073
2020
Q4
$278K Buy
+7,996
New +$225K ﹤0.01% 1581
2020
Q3
Sell
-46,652
Closed -$766K 1694
2020
Q2
$766K Buy
+46,652
New +$709K 0.02% 874
2020
Q1
Sell
-12,175
Closed -$259K 1040
2019
Q4
$259K Buy
+12,175
New +$270K ﹤0.01% 1222

Other funds holding ADNT

Michael Gelband's ADNT Position: Q4 2023 in Review

Michael Gelband sold out of Adient (ADNT) in Q4 2023, closing a stake of 38,059 shares — an estimated $1.4M sold.

Michael Gelband first reported a position in ADNT in Q4 2019 and held it in 5 quarters. The position peaked at $2.24M in Q1 2023. 303 funds tracked by Wall St. Rank hold ADNT as of Q4 2023.

  • Michael Gelband reported no remaining Adient position as of Q4 2023 after selling out during the quarter.
  • Michael Gelband sold 38,059 Adient shares in Q4 2023, an estimated $1.4M.
  • Michael Gelband first reported a position in Adient in Q4 2019 and held it in 5 quarters.
  • Michael Gelband's Adient position peaked at $2.24M in Q1 2023.
  • 303 funds tracked by Wall St. Rank held Adient as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.